Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review
2010 ◽
Vol 21
(3)
◽
pp. 218-226
◽
2014 ◽
Vol 62
(7)
◽
pp. 761
◽
2016 ◽
Vol 163
◽
pp. 53-58
◽
2017 ◽
Vol 6
(4)
◽
pp. 10
◽